Sections 19.3 states that during all phases of clinical development, including the use of small scale facilities or laboratories to manufacture batches of APIs for use in clinical trials, procedures should be in place to ensure that equipment is calibrated, clean, and suitable for its intended use. Your company procedures should direct the particular approach that is taken.
